Bone News and Research

RSS

Harvard successfully transplants regenerated esophagus into rat using bioreactor

Harvard Apparatus Regenerative Technology, Inc., a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announces that a research team led by Paolo Macchiarini, MD, PhD at Karolinska Institutet in Sweden has successfully transplanted a regenerated esophagus into a rat using a bioreactor developed by HART.

16 Apr 2014

Viewpoints: Obamacare dilemma -- some people dislike the law but embrace its provisions; are health costs falling?

Polls have consistently shown that even though the public opposes Obamacare, people like some of its most significant provisions. That's particularly true of the requirement that insurers ignore preexisting conditions when signing up customers for coverage.

16 Apr 2014

ulrich medical USA announces release of tezo spine implants in the U.S. market

ulrich medical USA, Inc., today announced the U.S. market release of the tezo spine implants for multiple surgical approaches to lumbosacral interbody fusion.

16 Apr 2014

New blood test accurately detects presence of breast cancer and monitors response to treatment

Johns Hopkins Kimmel Cancer Center investigators report they have designed a blood test that accurately detects the presence of advanced breast cancer and also holds promise for precisely monitoring response to cancer treatment.

15 Apr 2014

Drugs used to treat osteoporosis appear to prevent cell membrane repair

A class of drugs widely used to treat osteoporosis appears to impede a cell's ability to repair a protective outer membrane that helps determine what enters and exits, researchers report.

15 Apr 2014

New guidelines on management and return to play of Female Athlete Triad discussed at AMSSM

The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves three components: low energy availability with or without disordered eating, menstrual dysfunction and low bone mineral density.

15 Apr 2014

Nanotechnology unlocks new pathways for targeted drug delivery

Significant advances have been made in chemotherapy over the past decade, but targeting drugs to cancer cells while avoiding healthy tissues continues to be a major challenge.

15 Apr 2014

Study shows link between overuse injury rates in young athletes and their socioeconomic status

A Loyola University Medical Center study is reporting for the first time a link between overuse injury rates in young athletes and their socioeconomic status.

11 Apr 2014

Loyola study reports link between overuse injury rates and socioeconomic status in young athletes

A Loyola University Medical Center study is reporting for the first time a link between overuse injury rates in young athletes and their socioeconomic status.

11 Apr 2014

New procedure helps curtail complication rate associated with bone grafting

UT Arlington and Texas Health Arlington Memorial Hospital are investigating whether bone grown from the body's own stem cells can replace traditional types of bone grafting.

11 Apr 2014

Compressyn Band selected as finalist in Medical Design Excellence Awards for Implant and Tissue-Replacement Products Category

Dallen Medical, Inc. is pleased to announce that the Compressyn™ Band has been selected as a finalist in the Implant and Tissue-Replacement Products Category of the 17th Annual Medical Design Excellence Awards competition.

10 Apr 2014

BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML treatment

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a Phase 1/2 clinical study.

10 Apr 2014

Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.

10 Apr 2014

Red LED irradiation promotes cell transplantation in treatment of hypoxic-ischemic brain damage

A series of previous studies suggested that the neuronal differentiation rate of bone marrow mesenchymal stem cells during the in vitro culture reached 78-92%, but their in vivo transplantation efficiency, and survival and differentiation rates were very low.

10 Apr 2014

Stem cells culled from bone marrow may prove beneficial in stroke recovery

Stem cells culled from bone marrow may prove beneficial in stroke recovery, scientists at UC Irvine's Sue & Bill Gross Stem Cell Research Center have learned.

10 Apr 2014

Osiris Therapeutics receives $15 million cash payment from Mesoblast for Prochymal

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, announced that it has received the next $15 million cash payment from Mesoblast in accordance with the Purchase Agreement relating to the Prochymal business.

9 Apr 2014

Researchers receive NIH grant for pediatric acute myelogenous leukemia treatment

A $1.92 million grant from the National Institutes of Health (NIH) was awarded to a research team that focuses on new approaches for treatment of relapsed pediatric acute myelogenous leukemia (rAML), led by Yang Liu, PhD, Bothworth Chair and Director of the Center for Cancer and Immunology Research (CCIR) at Children's Research Institute of Children's National Health System, and Reuven Schore, MD, member of CCIR and attending physician in the Leukemia & Lymphoma Program of the Division of Oncology of the Center for Cancer and Blood Disorders.

9 Apr 2014

Researchers identify experimental drugs to block treatment-resistant leukemia

Research in mice and human cell lines has identified an experimental compound dubbed TTT-3002 as potentially one of the most potent drugs available to block genetic mutations in cancer cells blamed for some forms of treatment-resistant leukemia.

9 Apr 2014

DePuy Synthes Power Tools announces launch of Anspach EG1 High Speed Electric System

DePuy Synthes Power Tools announced today the global launch of the Anspach EG1 High Speed Electric System, a next generation high-speed electric drill with multiple attachments and accessories, designed for use in neurosurgery, otology and spinal procedures. The announcement was made here at the 2014 AANS Annual Scientific Meeting (American Association of Neurological Surgeons).

8 Apr 2014

Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

Fred Hutchinson Cancer Research Center scientists striving for new cancer cures - and the patients who stand to benefit from them - got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single contribution in Fred Hutch's history.

8 Apr 2014

Bone News and Research

Harvard successfully transplants regenerated esophagus into rat using bioreactor

Viewpoints: Obamacare dilemma -- some people dislike the law but embrace its provisions; are health costs falling?

ulrich medical USA announces release of tezo spine implants in the U.S. market

New blood test accurately detects presence of breast cancer and monitors response to treatment

Drugs used to treat osteoporosis appear to prevent cell membrane repair

New guidelines on management and return to play of Female Athlete Triad discussed at AMSSM

Nanotechnology unlocks new pathways for targeted drug delivery

Study shows link between overuse injury rates in young athletes and their socioeconomic status

Loyola study reports link between overuse injury rates and socioeconomic status in young athletes

New procedure helps curtail complication rate associated with bone grafting

Compressyn Band selected as finalist in Medical Design Excellence Awards for Implant and Tissue-Replacement Products Category

BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML treatment

Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

Red LED irradiation promotes cell transplantation in treatment of hypoxic-ischemic brain damage

Stem cells culled from bone marrow may prove beneficial in stroke recovery

Osiris Therapeutics receives $15 million cash payment from Mesoblast for Prochymal

Researchers receive NIH grant for pediatric acute myelogenous leukemia treatment

Researchers identify experimental drugs to block treatment-resistant leukemia

DePuy Synthes Power Tools announces launch of Anspach EG1 High Speed Electric System

Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News